Prediction of transition to psychosis from an at-risk mental state using structural neuroimaging, genetic, and environmental data

Front Psychiatry. 2023 Jan 19:13:1086038. doi: 10.3389/fpsyt.2022.1086038. eCollection 2022.

Abstract

Introduction: Psychosis is usually preceded by a prodromal phase in which patients are clinically identified as being at in an "At Risk Mental State" (ARMS). A few studies have demonstrated the feasibility of predicting psychosis transition from an ARMS using structural magnetic resonance imaging (sMRI) data and machine learning (ML) methods. However, the reliability of these findings is unclear due to possible sampling bias. Moreover, the value of genetic and environmental data in predicting transition to psychosis from an ARMS is yet to be explored.

Methods: In this study we aimed to predict transition to psychosis from an ARMS using a combination of ML, sMRI, genome-wide genotypes, and environmental risk factors as predictors, in a sample drawn from a pool of 246 ARMS subjects (60 of whom later transitioned to psychosis). First, the modality-specific values in predicting transition to psychosis were evaluated using several: (a) feature types; (b) feature manipulation strategies; (c) ML algorithms; (d) cross-validation strategies, as well as sample balancing and bootstrapping. Subsequently, the modalities whose at least 60% of the classification models showed an balanced accuracy (BAC) statistically better than chance level were included in a multimodal classification model.

Results and discussion: Results showed that none of the modalities alone, i.e., neuroimaging, genetic or environmental data, could predict psychosis from an ARMS statistically better than chance and, as such, no multimodal classification model was trained/tested. These results suggest that the value of structural MRI data and genome-wide genotypes in predicting psychosis from an ARMS, which has been fostered by previous evidence, should be reconsidered.

Keywords: ARMS; biomarker; machine learning; prognosis; schizophrenia.

Grants and funding

This study, VT received support from Fundação para a Ciência e a Tecnologia (FCT) Ph.D. fellowship PD/BD/114460/2016 and DSAIPA/DS/0065/2018 grants; DP received primary support from National Institute for Health Research (NIHR) PDF-2010-03-047 grant, and additionally from FCT FCT-IF/00787/2014, LISBOA-01–0145-FEDER-030907, and DSAIPA/DS/0065/2018 grants, and a European Commission (EC) Marie Curie Career Integration Grant (FP7-PEOPLE-2013-CIG 631952). EV was part-funded by the NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. IV was supported by EC’s Horizon 2020 Marie Skłodowska-Curie grant (Ref. 754550, project BITRECS) and “La Caixa” Foundation (LCF/PR/GN18/50310006).